These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22442734)

  • 1. Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study.
    Liang H; Baudouin C; Labbe A; Riancho L; Brignole-Baudouin F
    PLoS One; 2012; 7(3):e33913. PubMed ID: 22442734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
    Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
    Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay.
    Liang H; Baudouin C; Faure MO; Lambert G; Brignole-Baudouin F
    Mol Vis; 2009 Aug; 15():1690-9. PubMed ID: 19710954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live conjunctiva-associated lymphoid tissue analysis in rabbit under inflammatory stimuli using in vivo confocal microscopy.
    Liang H; Baudouin C; Dupas B; Brignole-Baudouin F
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1008-15. PubMed ID: 19850837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
    Nagstrup AH
    Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
    Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
    Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits.
    Liang H; Brignole-Baudouin F; Rabinovich-Guilatt L; Mao Z; Riancho L; Faure MO; Warnet JM; Lambert G; Baudouin C
    Mol Vis; 2008 Jan; 14():204-16. PubMed ID: 18347566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells.
    Hedengran A; Freiberg J; May Hansen P; Boix-Lemonche G; Utheim TP; Dartt DA; Petrovski G; Heegaard S; Kolko M
    J Optom; 2024; 17(1):100481. PubMed ID: 37788596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system.
    Ryan G; Fain JM; Lovelace C; Gelotte KM
    BMC Ophthalmol; 2011 Apr; 11():8. PubMed ID: 21510881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
    Wu JH; Wang TH; Huang JY; Su CC
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
    Kahook MY; Noecker R
    Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
    Ammar DA; Kahook MY
    Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model.
    Liang H; Baudouin C; Daull P; Garrigue JS; Brignole-Baudouin F
    Mol Vis; 2012; 18():2195-204. PubMed ID: 22919267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the toxicity profile of benzalkonium chloride-preserved tafluprost and SofZia-preserved travoprost applied to the ocular surface.
    Kanamoto T; Kiuchi Y; Tanito M; Mizoue S; Naito T; Teranishi S; Hirooka K; Rimayanti U;
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):156-64. PubMed ID: 25710276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits.
    Brignole-Baudouin F; Desbenoit N; Hamm G; Liang H; Both JP; Brunelle A; Fournier I; Guerineau V; Legouffe R; Stauber J; Touboul D; Wisztorski M; Salzet M; Laprevote O; Baudouin C
    PLoS One; 2012; 7(11):e50180. PubMed ID: 23209668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prostaglandin analogs on blood flow velocity and resistance in the ophthalmic artery of rabbits.
    Giannico AT; Lima L; Shaw GC; Russ HH; Froes TR; Montiani-Ferreira F
    Arq Bras Oftalmol; 2016 Feb; 79(1):33-6. PubMed ID: 26840164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
    Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
    Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
    Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.